Cardlytics, Inc. Income Statement
CDLX|8 years of annual SEC 10-K data (FY2018-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 8 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$233M
FY2025
Gross Profit
N/A
FY2025
Operating Income
-$102M
FY2025
Net Income
-$103M
FY2025
Cardlytics, Inc. reported $233M in revenue and $103M in net loss for FY2025. Revenue has grown at a 10.9% compound annual rate over the past 7 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $233.3M | $278.3M | $309.2M | $186.9M | $210.4M | $150.7M | $130.4M | $112.8M |
| SG&A Expense | $47.3M | $56.5M | $58.8M | $46.5M | $36.7M | $34.2M | $20.1M | $21.4M |
| R&D Expense | $39.8M | $49.6M | $51.4M | $17.5M | $11.7M | $16.2M | $12.2M | $13.9M |
| Operating Income | -$101.8M | -$195.5M | -$135.7M | -$53.9M | -$17.3M | -$40.9M | -$17.1M | -$56.2M |
| Interest Expense | - | - | $3.8M | $12.7M | $3.3M | $3.3M | -$8.2M | -$6.2M |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$103.5M | -$189.3M | -$134.7M | -$55.4M | -$17.1M | -$53.0M | -$19.6M | -$75.7M |
| EPS (Basic) | -$3.69 | -$13.92 | -$3.99 | -$2.04 | - | - | - | - |
| EPS (Diluted) | -$3.69 | -$13.92 | - | - | -$0.72 | -$2.79 | -$7.86 | -$32.48 |
| Shares Outstanding | 51.3M | 39.7M | - | - | 23.7M | 19.1M | 3.2M | 3.4M |
| Operating Margin | -43.6% | -70.3% | -43.9% | -28.8% | -8.2% | -27.2% | -13.1% | -49.8% |
| Profit Margin | -44.4% | -68.0% | -43.6% | -29.6% | -8.2% | -35.2% | -15.1% | -67.1% |